Smith+Nephew is a leading portfolio medical technology company across Orthopaedics, Sports Medicine, ENT and Advanced Wound Management.
Smith+Nephew's Orthopaedics portfolio includes an innovative range of hip and knee implants used to replace diseased, damaged or worn joints, robotics-assisted and enabling technologies, and services that empower surgeons. It also includes trauma products used to stabilise severe fractures and correct bone deformities.
Smith+Nephew's Sports Medicine portfolio includes advanced technology, instruments and implants that enable surgeons to perform minimally invasive surgery including the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip and small joints.
Smith+Nephew's Advanced Wound Management portfolio provides comprehensive solutions to meet broad and complex clinical needs and to help healthcare professionals reduce the human and economic consequences of wounds. These include products for the treatment of acute and chronic wounds such as leg, diabetic and pressure ulcers, burns, and post-operative wounds.
Smith+Nephew's Ear, Nose and Throat (ENT) portfolio consists of products for epistaxis, laryngeal and soft palate reduction, septoplasty, turbinate reduction, sinus surgery, tympanostomy, and tonsil and adenoid removal.